NEXT San Antonio
NEXT San Antonio
San Antonio, Texas, United States6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endometrium neoplasm, esophageal cancer, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric cancer, gastric neoplasm, intestinal disorder, neoplasm, rectal disorder, stomach disorder, uterine disorder | Recruiting | Phase 1 | 2026-08-27 | NCT07227168 | |
| Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-08-13 | NCT06384352 | |
| Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, breast cancer, breast disorder, breast neoplasm, cervix disorder, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, skin disorder, uterine disorder | Recruiting | Phase 1 | 2026-07-22 | NCT07524322 | |
| A Study of PYX-201 in Advanced Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2026-06-30 | NCT05720117 | |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm | Recruiting | Phase 1 | 2026-04-16 | NCT06959706 | |
| DPTX3186 in Wnt Pathway Activated Solid Tumors | Solid Tumors | Recruiting | Phase 1 | 2026-01-12 | NCT07312903 |